| 812 | 1 | 144 |
| 下载次数 | 被引频次 | 阅读次数 |
为了研究朊病毒感染对细胞氧化供能的主要途径—三羧酸循环关键催化酶的影响。使用ATP检测试剂盒检测朊病毒感染后细胞的ATP表达情况，采用蛋白免疫印迹方法检测朊病毒感染细胞中三羧酸循环关键催化酶的表达情况；使用细胞免疫荧光对催化酶进行细胞定位；应用线粒体分离试剂盒分离线粒体，检测线粒体中催化酶的表达情况。结果显示朊病毒感染后的细胞ATP表达水平明显降低，进一步检测三羧酸循环过程中三个主要的催化酶，发现这三个催化酶在朊病毒感染的细胞中表达量明显降低，免疫荧光实验显示催化酶与线粒体标志蛋白具有空间共定位现象，并发现在朊病毒感染细胞的线粒体中这三个催化酶的表达也显著降低。本研究发现朊病毒感染细胞中三羧酸循环催化酶的表达量明显降低，导致ATP产能下降，影响细胞代谢水平。
Abstract：We measured levels of the key catalytic enzymes of the tricarboxylic acid cycle(TCAC),which is the main pathway of oxidative-energy supply in cells after prion infections. Levels of adenosine triphosphate(ATP)in prion-infected cells were measured by an ATP detection kit. Levels of the key catalytic enzymes of the TCAC in prion-infected cells were measured by western blotting. Immunofluorescence of cells was used to test the location of catalytic enzymes. A mitochondrial isolation kit was used to isolate mitochondria and measure levels of catalytic enzymes within them. ATP levels were reduced significantly in prion-infected cells. Levels of three enzymes were reduced in prion-infected cells. Catalytic enzymes were colocalized with mitochondrial proteins according to immunofluorescence analyses. Extraction of mitochondrial components from cells revealed the levels of these three catalytic enzymes to be reduced significantly in the mitochondria of prion-infected cells. This study found levels of catalyzing enzymes in the TCAC decreased significantly after prion infection,which resulted in a decrease in ATP production and affected cell metabolism.
[1] Sto?da N I,Zavalishin I A,[Prion diseases][J]. Zh Nevrol Psikhiatr Im S S Korsakova,2012,112(9 Pt2),59-63.
[2] Lin M T,Beal M F,Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases[J].Nature,2006,443(7113),787-95.
[3] Dobolyi A, Bago A, Palkovits M, Nemeria N S,Jordan F, Doczi J, Ambrus A, Adam-Vizi V,Chinopoulos C. Exclusive neuronal detection of KGDHC-specific subunits in the adult human brain cortex despite pancellular protein lysine succinylation[J].Brain Struct Funct,2020,225(2),639-667.
[4] Fernie A R,Carrari F,Sweetlove L J. Respiratory metabolism:glycolysis, the TCA cycle and mitochondrial electron transport[J]. Curr Opin Plant Biol,2004,7(3),254-61.
[5] Martínez-Reyes I,Chandel N S. Mitochondrial TCA cycle metabolites control physiology and disease[J]. Nat Commun,2020,11(1),102.
[6] Gibson C M,Mallett T C,Claiborne A,Caparon M G.Contribution of NADH oxidase to aerobic metabolism of Streptococcus pyogenes[J]. J Bacteriol 2000,182(2),448-455.
[7] Butterworth R F,Besnard A M. Thiamine-dependent enzyme changes in temporal cortex of patients with Alzheimer's disease[J]. Metab Brain Dis,1990,5(4),179-184.
[8] Mastrogiacoma F,Lindsay J G,Bettendorff L,Rice J,Kish S J. Brain protein and alpha-ketoglutarate dehydrogenase complex activity in Alzheimer's disease[J]. Ann Neurol,1996,39(5),592-598.
[9] Gibson G E,Sheu K F,Blass J P,Baker A,Carlson K C,Harding B,Perrino P. Reduced activities of thiaminedependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease[J]. Arch Neurol,1988,45(8),836-840.
[10]Gibson G E,Kingsbury A E,Xu H,Lindsay J G,Daniel S,Foster O J,Lees A J,Blass J P. Deficits in a tricarboxylic acid cycle enzyme in brains from patients with Parkinson's disease[J]. Neurochem Int,2003,43(2),129-315.
[11]Jiménez-Jiménez F J, Molina J A, Hernánz A,Fernández-Vivancos E, de Bustos F, Barcenilla B,Gómez-Escalonilla C,Zurdo M,Berbel A,Villanueva C. Cerebrospinal fluid levels of thiamine in patients with Parkinson's disease[J]. Neurosci Lett,1999,271(1),33-36.
[12]Mizuno Y,Matuda S,Yoshino H,Mori H,Hattori N,Ikebe S. An immunohistochemical study on alphaketoglutarate dehydrogenase complex in Parkinson's disease[J].Ann Neurol,1994,35(2),204-210.
[13]Park L C,Albers D S,Xu H,Lindsay J G,Beal M F,Gibson G E. Mitochondrial impairment in the cerebellum of the patients with progressive supranuclear palsy[J]. J Neurosci Res,2001,66(5),1028-1034.
[14]Albers D S,Augood S J,Park L C,Browne S E,Martin D M,Adamson J,Hutton M,Standaert D G,Vonsattel J P,Gibson G E,Beal M F. Frontal lobe dysfunction in progressive supranuclear palsy:evidence for oxidative stress and mitochondrial impairment[J]. J Neurochem,2000,74(2),878-881.
[15]Yoon W H,Sandoval H,Nagarkar-Jaiswal S,Jaiswal M,Yamamoto S,Haelterman N A,Putluri N,Putluri V,Sreekumar A,Tos T,Aksoy A,Donti T,Graham B H, Ohno M, Nishi E, Hunter J, Muzny D M,Carmichael J,Shen J,Arboleda V A,Nelson S F,Wangler M F,Karaca E,Lupski J R,Bellen H J. Loss of Nardilysin,a Mitochondrial Co-chaperone for α-Ketoglutarate Dehydrogenase, Promotes mTORC1Activation and Neurodegeneration[J]. Neuron,2017,93(1),115-131.
[16]Gandbhir O, Sundaram P. Effect of AmyTrap, an amyloid-β binding drug,on Aβ induced mitochondrial dysfunction and tau phosphorylation in cultured neuroblastoma cells[J]. Metab Brain Dis, 2020, 35(6),923-931.
[17]Anderson N M, Li D, Peng H L, Laroche F J,Mansour M R, Gjini E, Aioub M, Helman D J,Roderick J E,Cheng T,Harrold I,Samaha Y,Meng L,Amsterdam A,Neuberg D S,Denton T T,Sanda T,Kelliher M A,Singh A,Look A T,Feng H. The TCA cycle transferase DLST is important for MYCmediated leukemogenesis[J]. Leukemia,2016,30(6),1365-1374.
[18]Ooi A,Furge K A. Fumarate hydratase inactivation in renal tumors:HIF1α,NRF2,and"cryptic targets"of transcription factors[J]. Chin J Cancer,2012,31(9),413-420.
[19]Tyrakis P A, Yurkovich M E, Sciacovelli M,Papachristou E K,Bridges H R,Gaude E,Schreiner A, D'Santos C, Hirst J, Hernandez-Fernaud J,Springett R, Griffiths J R, Frezza C. Fumarate hydratase loss causes combined respiratory chain defects[J]. Cell Rep,2017,21(4),1036-1047.
[20]Zhu T,Chen J L,Wang Q,Shao W,Qi B. Modulation of mitochondrial dynamics in neurodegenerative diseases:an insight into Prion diseases[J]. Front Aging Neurosci,2018,10,336.
[21]Sudarshan S,Sourbier C,Kong H S,Block K,Valera Romero V A, Yang Y, Galindo C, Mollapour M,Scroggins B, Goode N, Lee M J, Gourlay C W,Trepel J, Linehan W M, Neckers L. Fumarate hydratase deficiency in renal cancer induces glycolytic addiction and hypoxia-inducible transcription factor1alpha stabilization by glucose-dependent generation of reactive oxygen species[J]. Mol Cell Biol,2009,29(15),4080-4090.
[22]Maimaitiming A,Xiao K,Hu C,Chen J,Yang X H,Zhou D H,Gao L P,Dong X P,Shi Q. Aberrant Decrease of the Endogenous SIRT3 and increases of acetylated proteins in scrapie-Infected cell Line SMBS15 and in the brains of experimental mice[J]. ACS Chem Neurosci,2019,10(10),4293-4302.
[23]Villa R F, Arnaboldi R, Ghigini B, Gorini A.Mitochondrial factors involved in Parkinson's disease by MPTP toxicity in Macaca fascicularis and drug effect[J].Neurochem Res,1992,17(11),1147-1154.
[24]Cedarbaum J M,Sheu K F,Harding B J,Blass J P,Javoy-Agid F, Agid Y. Deficiency of glutamate dehydrogenase in postmortem brain samples from parkinsonian putamen[J]. Ann Neurol,1990,28(1),111-112.
[25]Igamberdiev A U. Citrate valve integrates mitochondria into photosynthetic metabolism[J]. Mitochondrion,2020,52,218-230.
[26]Garabadu D, Agrawal N, Sharma A, Sharma S.Mitochondrial metabolism:a common link between neuroinflammation and neurodegeneration[J]. Behav Pharmacol,2019,30(8),642-652.
[27]Gellerich F N,Gizatullina Z,Trumbeckaite S,Nguyen H P,Pallas T,Arandarcikaite O,Vielhaber S,Seppet E, Striggow F. The regulation of OXPHOS by extramitochondrial calcium[J]. Biochim Biophys Acta,2010,1797(6-7),1018-1027.
[28]Kanuru M,Aradhyam G K. Chaperone-like activity of calnuc prevents amyloid aggregation[J]. Biochemistry,2017,56(1),149-159.
[29]Burke P J. Mitochondria,bioenergetics and apoptosis in cancer[J]. Trends Cancer,2017,3(12),857-870.
基本信息:
DOI：10.13242/j.cnki.bingduxuebao.004143
中图分类号:R742.9
引用信息:
[1]陈冬冬,高利萍,刘楚眸,等.朊病毒感染对细胞中三羧酸循环关键催化酶的影响研究[J].病毒学报,2022,38(03):666-674.DOI:10.13242/j.cnki.bingduxuebao.004143.
基金信息:
传染病预防控制国家重点实验室重点课题（项目号：2021SKLID101）;题目：细胞因子IP-10、M-CSF在朊病毒感染中神经保护或伤作用的研究; 国家重点研发计划（项目号：2020YFE0205700），题目：中国塞拉利昂“一带一路”联合实验室建设与重要传染病病原学研究~~